SlideShare una empresa de Scribd logo
1 de 8
Reimbursement were prices are negotiated based on value for the country as a whole, by using existing health technology assessment :  Case Study using Blood Glucose Test Strips Chris Cameron,  Health Economist, Canadian Agency for Drugs and Technologies in Health  CHSRF iHEA Pre-Conference Symposium, July 11, 2011
Health Technology Assessment (HTA) ,[object Object],[object Object],[object Object]
Option: pan-Canadian HTA-based price negotiation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Example – Blood Glucose Test Strips ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example – Blood Glucose Test Strips (c) VBP of test strips at cost-effectiveness threshold of marginal sub-group  (a) (b) Current pricing of test strips in Canada (dashed line) a) Diminishing marginal utility of SMBG HTA-based price reduction from $0.76 to $0.30 using would save drug plans >$150 million annually and not compromise the health of Canadians
Be nefits – pan-Canadian HTA-based price Negotiation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Challenges – pan-Canadian HTA-based Price Negotiation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Conclusion   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
Challenges and Innovation in Canadian Access to Treatments and Innovation
Challenges and Innovation in Canadian Access to Treatments and InnovationChallenges and Innovation in Canadian Access to Treatments and Innovation
Challenges and Innovation in Canadian Access to Treatments and Innovation
 
Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...
 
Operationalising Value-based Pricing: Do we know what we value and what we ar...
Operationalising Value-based Pricing: Do we know what we value and what we ar...Operationalising Value-based Pricing: Do we know what we value and what we ar...
Operationalising Value-based Pricing: Do we know what we value and what we ar...
 
CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?
 
Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
 Are Wider Societal Effects Considered in Healthcare Decision-making? An over... Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
 
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...
 
Pharma funding of patient groups: the building blocks of ethical and appropri...
Pharma funding of patient groups: the building blocks of ethical and appropri...Pharma funding of patient groups: the building blocks of ethical and appropri...
Pharma funding of patient groups: the building blocks of ethical and appropri...
 
Aaron S. Kesselheim, Prescription Drug Prices and "Value"
Aaron S. Kesselheim, Prescription Drug Prices and "Value"Aaron S. Kesselheim, Prescription Drug Prices and "Value"
Aaron S. Kesselheim, Prescription Drug Prices and "Value"
 
ISPOR poster ri lwcp 140515
ISPOR poster   ri lwcp  140515ISPOR poster   ri lwcp  140515
ISPOR poster ri lwcp 140515
 
How Timely is Canada’s Medication Review and Approval Process?
How Timely is Canada’s Medication Review and Approval Process?How Timely is Canada’s Medication Review and Approval Process?
How Timely is Canada’s Medication Review and Approval Process?
 
The Mad, Fairytale World of Drug Approval in Canada
The Mad, Fairytale World of Drug Approval in CanadaThe Mad, Fairytale World of Drug Approval in Canada
The Mad, Fairytale World of Drug Approval in Canada
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
 
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
 
Devlin mcda philadelphia ispor 150515
Devlin  mcda philadelphia ispor 150515 Devlin  mcda philadelphia ispor 150515
Devlin mcda philadelphia ispor 150515
 
Adrian Towse Presentation - Affordability
Adrian Towse Presentation - Affordability Adrian Towse Presentation - Affordability
Adrian Towse Presentation - Affordability
 
Deborah Gersh, Data in Value- Based Health Care
Deborah Gersh, Data in Value- Based Health CareDeborah Gersh, Data in Value- Based Health Care
Deborah Gersh, Data in Value- Based Health Care
 
Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...
 

Similar a WHAT IF: The entry of new pharmaceuticals was managed and their prices were negotiated based on value for the country as a whole, by using existing health technology assessment capacity?

BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAPBIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
Nathan White, CPC
 
BIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studiesBIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studies
Nathan White, CPC
 
Apr 13 improving methods and processes codependent techs mg
Apr 13 improving methods and processes codependent techs mgApr 13 improving methods and processes codependent techs mg
Apr 13 improving methods and processes codependent techs mg
Office of Health Economics
 

Similar a WHAT IF: The entry of new pharmaceuticals was managed and their prices were negotiated based on value for the country as a whole, by using existing health technology assessment capacity? (20)

What can we learn from other countries?
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?
 
RDD 2020 Day 1 AM - Durhane Wong-Rieger
RDD 2020 Day 1 AM - Durhane Wong-RiegerRDD 2020 Day 1 AM - Durhane Wong-Rieger
RDD 2020 Day 1 AM - Durhane Wong-Rieger
 
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAPBIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
 
BIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studiesBIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studies
 
Principles of Pharmacoeconomics and ...
Principles of Pharmacoeconomics and                                          ...Principles of Pharmacoeconomics and                                          ...
Principles of Pharmacoeconomics and ...
 
Apr 13 improving methods and processes codependent techs mg
Apr 13 improving methods and processes codependent techs mgApr 13 improving methods and processes codependent techs mg
Apr 13 improving methods and processes codependent techs mg
 
Health Technology Assessment: Comparison between UK and Canada Processes by D...
Health Technology Assessment: Comparison between UK and Canada Processes by D...Health Technology Assessment: Comparison between UK and Canada Processes by D...
Health Technology Assessment: Comparison between UK and Canada Processes by D...
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
 
ADAPTIVE PATHWAYS
ADAPTIVE PATHWAYSADAPTIVE PATHWAYS
ADAPTIVE PATHWAYS
 
The Impact Global Pharma Cost Containment Methods in APAC
The Impact Global Pharma Cost Containment Methods in APACThe Impact Global Pharma Cost Containment Methods in APAC
The Impact Global Pharma Cost Containment Methods in APAC
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
 
Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery
 
Webinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug PricingWebinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug Pricing
 
The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Techno...
The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Techno...The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Techno...
The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Techno...
 
Day 2: CORD 2021 Fall Conference Slides
Day 2: CORD 2021 Fall Conference SlidesDay 2: CORD 2021 Fall Conference Slides
Day 2: CORD 2021 Fall Conference Slides
 
Planning SMART Webinar: April 26, 2022
Planning SMART Webinar: April 26, 2022Planning SMART Webinar: April 26, 2022
Planning SMART Webinar: April 26, 2022
 
Bringing Rare Disease Drugs to Canada Opportunities, Challenges, and More Cha...
Bringing Rare Disease Drugs to Canada Opportunities, Challenges, and More Cha...Bringing Rare Disease Drugs to Canada Opportunities, Challenges, and More Cha...
Bringing Rare Disease Drugs to Canada Opportunities, Challenges, and More Cha...
 
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
 
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
 
Value based healthcare
Value based healthcareValue based healthcare
Value based healthcare
 

Más de CFHI-FCASS

Mythbusters Evaluation
Mythbusters EvaluationMythbusters Evaluation
Mythbusters Evaluation
CFHI-FCASS
 
Augmenter la capacité d’une participation significative
Augmenter la capacité d’une participation significativeAugmenter la capacité d’une participation significative
Augmenter la capacité d’une participation significative
CFHI-FCASS
 
Increasing Capacity for Meaningful Engagement
Increasing Capacity for Meaningful EngagementIncreasing Capacity for Meaningful Engagement
Increasing Capacity for Meaningful Engagement
CFHI-FCASS
 
L simard cdn-masterclass_presentation-17-05-11_fr
L simard cdn-masterclass_presentation-17-05-11_frL simard cdn-masterclass_presentation-17-05-11_fr
L simard cdn-masterclass_presentation-17-05-11_fr
CFHI-FCASS
 
L simard cdn-masterclass_presentation-17-05-11
L simard cdn-masterclass_presentation-17-05-11L simard cdn-masterclass_presentation-17-05-11
L simard cdn-masterclass_presentation-17-05-11
CFHI-FCASS
 
Knowledge Transfer & Exchange
Knowledge Transfer & ExchangeKnowledge Transfer & Exchange
Knowledge Transfer & Exchange
CFHI-FCASS
 
What if: A sliding scale were used to reimburse generic drugs to effectively ...
What if: A sliding scale were used to reimburse generic drugs to effectively ...What if: A sliding scale were used to reimburse generic drugs to effectively ...
What if: A sliding scale were used to reimburse generic drugs to effectively ...
CFHI-FCASS
 
Diagnosing the fiscal viability of healthcare system Canada
Diagnosing the fiscal viability of healthcare system CanadaDiagnosing the fiscal viability of healthcare system Canada
Diagnosing the fiscal viability of healthcare system Canada
CFHI-FCASS
 

Más de CFHI-FCASS (20)

Mythbusters Evaluation
Mythbusters EvaluationMythbusters Evaluation
Mythbusters Evaluation
 
Augmenter la capacité d’une participation significative
Augmenter la capacité d’une participation significativeAugmenter la capacité d’une participation significative
Augmenter la capacité d’une participation significative
 
Increasing Capacity for Meaningful Engagement
Increasing Capacity for Meaningful EngagementIncreasing Capacity for Meaningful Engagement
Increasing Capacity for Meaningful Engagement
 
L simard cdn-masterclass_presentation-17-05-11_fr
L simard cdn-masterclass_presentation-17-05-11_frL simard cdn-masterclass_presentation-17-05-11_fr
L simard cdn-masterclass_presentation-17-05-11_fr
 
L simard cdn-masterclass_presentation-17-05-11
L simard cdn-masterclass_presentation-17-05-11L simard cdn-masterclass_presentation-17-05-11
L simard cdn-masterclass_presentation-17-05-11
 
Restructuration des services de santé et hospitaliers L’expérience de l’Ontario
Restructuration des services de santé et hospitaliers L’expérience de l’Ontario Restructuration des services de santé et hospitaliers L’expérience de l’Ontario
Restructuration des services de santé et hospitaliers L’expérience de l’Ontario
 
Les dépenses en Santé au Canada : La gestion pendant une récession (1990-1999)
Les dépenses en Santé au Canada : La gestion pendant une récession (1990-1999) Les dépenses en Santé au Canada : La gestion pendant une récession (1990-1999)
Les dépenses en Santé au Canada : La gestion pendant une récession (1990-1999)
 
Réforme des services de Santé en Saskatchewan dans les années 1990 : Leçons d...
Réforme des services de Santé en Saskatchewan dans les années 1990 : Leçons d...Réforme des services de Santé en Saskatchewan dans les années 1990 : Leçons d...
Réforme des services de Santé en Saskatchewan dans les années 1990 : Leçons d...
 
Current state of NHS reforms
Current state of NHS reformsCurrent state of NHS reforms
Current state of NHS reforms
 
Restructuring Health and Hospital Services: The Ontario Experience
Restructuring Health and Hospital Services: The Ontario ExperienceRestructuring Health and Hospital Services: The Ontario Experience
Restructuring Health and Hospital Services: The Ontario Experience
 
Healthcare reform in Saskatchewan in the 1990s: Lessons from the Minister of ...
Healthcare reform in Saskatchewan in the 1990s: Lessons from the Minister of ...Healthcare reform in Saskatchewan in the 1990s: Lessons from the Minister of ...
Healthcare reform in Saskatchewan in the 1990s: Lessons from the Minister of ...
 
Canadian health spending: Managing in a downturn (1990-1999)
Canadian health spending: Managing in a downturn (1990-1999)Canadian health spending: Managing in a downturn (1990-1999)
Canadian health spending: Managing in a downturn (1990-1999)
 
Knowledge Transfer & Exchange
Knowledge Transfer & ExchangeKnowledge Transfer & Exchange
Knowledge Transfer & Exchange
 
What if: A sliding scale were used to reimburse generic drugs to effectively ...
What if: A sliding scale were used to reimburse generic drugs to effectively ...What if: A sliding scale were used to reimburse generic drugs to effectively ...
What if: A sliding scale were used to reimburse generic drugs to effectively ...
 
WHAT IF: Medical saving accounts were established?
WHAT IF: Medical saving accounts were established?WHAT IF: Medical saving accounts were established?
WHAT IF: Medical saving accounts were established?
 
WHAT IF: Group-based profit-sharing strategies aligned physician incentives w...
WHAT IF: Group-based profit-sharing strategies aligned physician incentives w...WHAT IF: Group-based profit-sharing strategies aligned physician incentives w...
WHAT IF: Group-based profit-sharing strategies aligned physician incentives w...
 
WHAT IF: The price of new provider fees were coordinated across Canada, suppo...
WHAT IF: The price of new provider fees were coordinated across Canada, suppo...WHAT IF: The price of new provider fees were coordinated across Canada, suppo...
WHAT IF: The price of new provider fees were coordinated across Canada, suppo...
 
WHAT IF: A health impact fund rewarded innovation and managed spending on new...
WHAT IF: A health impact fund rewarded innovation and managed spending on new...WHAT IF: A health impact fund rewarded innovation and managed spending on new...
WHAT IF: A health impact fund rewarded innovation and managed spending on new...
 
Diagnosing the fiscal viability of healthcare system Canada
Diagnosing the fiscal viability of healthcare system CanadaDiagnosing the fiscal viability of healthcare system Canada
Diagnosing the fiscal viability of healthcare system Canada
 
WHAT IF: Social insurance could pay for prescription drugs?
WHAT IF: Social insurance could pay for prescription drugs?WHAT IF: Social insurance could pay for prescription drugs?
WHAT IF: Social insurance could pay for prescription drugs?
 

Último

College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
perfect solution
 

Último (20)

Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
 
O898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
O898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In AhmedabadO898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
O898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur  Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Guntur  Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
 
Call Girls Agra Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Agra Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Agra Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Agra Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Call Girls Haridwar Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Haridwar Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 

WHAT IF: The entry of new pharmaceuticals was managed and their prices were negotiated based on value for the country as a whole, by using existing health technology assessment capacity?

  • 1. Reimbursement were prices are negotiated based on value for the country as a whole, by using existing health technology assessment : Case Study using Blood Glucose Test Strips Chris Cameron, Health Economist, Canadian Agency for Drugs and Technologies in Health CHSRF iHEA Pre-Conference Symposium, July 11, 2011
  • 2.
  • 3.
  • 4.
  • 5. Example – Blood Glucose Test Strips (c) VBP of test strips at cost-effectiveness threshold of marginal sub-group (a) (b) Current pricing of test strips in Canada (dashed line) a) Diminishing marginal utility of SMBG HTA-based price reduction from $0.76 to $0.30 using would save drug plans >$150 million annually and not compromise the health of Canadians
  • 6.
  • 7.
  • 8.

Notas del editor

  1. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians
  2. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians
  3. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians
  4. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians
  5. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians
  6. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians
  7. Private, not-for-profit organization founded in 1989 by the F/P/T Deputy Ministers of Health Funded by Health Canada, the provinces and territories Provides evidence-based information about the effectiveness and efficiency of drugs and other health technologies Contributes to the sustainability of our health care system and improved health outcomes for all Canadians